Neurotoxicity Syndromes - 25 Studies Found
| Terminated |
: A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity : Neurotoxicity Syndromes : 2005-09-12 : Drug: Dextromethorphan Patients will receive an inert carrier with or without dextromethorphan. The stud |
| Completed |
: To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity : Neurotoxicity Syndromes : 2015-06-09 :
|
| Completed |
: Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients : Neurotoxicity : 2015-07-11 : Drug: monosialoganglioside 40mg in the vein on day 1 - day 8 of each 21 days cycle. Number of Cycles: 2 |
| Terminated |
: Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway : Neurotoxicity : 2011-10-18 : Drug: Vitamin D3 Vitamin D3 will be administered at a dose of 2000 IU orally daily starting on day 1 of |
| Completed |
: Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer : Neurotoxicity : 2015-05-03 :
|
| Completed |
: Protective Effect of Mangafodipir Against Oxaliplatin Neurotoxicity :
: 2008-07-31 : Drug: Mangafodipir Mangafodipir (0.5 ml/kg) is administered as a 30 minutes infusion just after each adm |
| Completed |
: Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery :
: 2006-04-19 :
|
| Completed |
: Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin :
|
| Withdrawn |
: Scopolamine Treatment for Patients With Organophosphate Poisoning : Neurotoxicity Syndromes : 2006-10-17 : Drug: Placebo IV placebo q4h |
| Completed |
: Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy :
|